Epoch Premium is a collection of our investigative journalism and in-depth news analysis as well as four weekly magazines with inspiring stories about life, arts, health and food.

Epoch Premium content is curated exclusively for our subscribers. Here are a few examples. You can access all this content for just $1.

Limited time offer. Cancel anytime.

Exclusive Infographics

INFOGRAPHIC: Approved and Non-FDA Approved COVID-19 Treatments

Since the onset of the COVID-19 pandemic two years ago, hundreds of studies have examined the efficacy of dozens of drugs and other compounds in treating the disease. While the research is still ongoing, a sizable number of treatments have shown promise. A growing number of them have been authorized by the U.S. government, though virtually all of those approved sport hefty price tags.

By Petr Svab

Premium Articles

Elon Musk Reveals His Likely Choice for President in 2024

Facts Matter (June 9): 100% of Cancer Patients in Remission After Monoclonal Antibody Trial: ‘Tumors Just Vanished’

CDC Wants Its COVID Regime Made Permanent

Inspired

Atheist Dad Is Transformed After Glimpse of Heaven as Toddler Son Is Taken Off Life Support

Reader’s Turn

WIL THOMAS

Subscriber of The Epoch Times

“It is so refreshing to see actual journalism again! I studied journalism and understand what it means – to report the facts as closely to the truth as you can manage while understanding the reporter will always have some bias of their own. Yet the facts, even if incomplete, are to be reported truthfully. This is not what we get from most “mainstream” media. They have been controlled by the deep state for decades. Someone cares what the majority of us think about people and events and is spending a LOT of money to influence our thinking. I greatly admire the work and dedication to integrity I see in The Epoch Times. Thank you! You inspire others with your efforts. Right is winning!”

Copyright © 2022 The Epoch Times, All rights reserved.

The Epoch Times, 229 W 28 St, Fl. 5, New York, NY 10001

You are receiving this email because you recently registered for a free account with The Epoch Times. In the days ahead you will receive compelling letters from our editorial staff, practical guides on how to get the most out of our publication and exclusive offers. Want us to stop emailing you? Manage your email preferences here.